Is FibroScan (transient elastography) appropriate for use in children aged ≥5 years (≥15 kg) and in individuals younger than 35 years?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

FibroScan Use in Children and Young Adults

Yes, FibroScan (transient elastography) is appropriate for use in children aged ≥5 years and individuals under 35 years, though technical reliability improves significantly after age 6 years, and interpretation requires age-specific reference values.

Age-Specific Considerations for Pediatric Use

Children Under 6 Years

  • Feasibility is limited in very young children 1, 2
  • In children 0-2 years, reliability drops to only 36% 2
  • After age 2 years, reliable results can be obtained in approximately 80% of cases 2
  • Movement artifacts significantly increase invalid measurements in younger children, making sedation sometimes necessary 1

Children 6 Years and Older

  • This is the optimal age for reliable unsedated measurements 1
  • Technical success rates approach those seen in adults
  • The 2025 AASLD systematic review confirms that imaging-based noninvasive liver disease assessment (including FibroScan) is "likely as accurate in the pediatric population as in adults" 3

Critical Technical Requirements

Age-Dependent Reference Values

You must use age-specific cutoffs—adult values do not apply to children:

  • Ages 0-5 years: upper limit of normal 5.96 kPa 1
  • Ages 6-11 years: upper limit of normal 6.65 kPa 1
  • Ages 12-18 years: upper limit of normal 6.82 kPa 1
  • Median liver stiffness increases significantly with age (4.40 → 4.73 → 5.1 kPa across age groups, p=0.001) 1

Sex Differences

  • Girls aged 11-18 years show significantly lower median stiffness than boys (4.7 vs 5.6 kPa, p<0.005) 1
  • Consider sex-specific interpretation in adolescents

Use in Adults Under 35 Years

FibroScan is fully validated and appropriate for adults under 35 years. The 2017 AGA guideline establishes that vibration-controlled transient elastography has been "validated in large cohorts worldwide in a spectrum of liver diseases" 4, and the 2025 AASLD systematic review included 240 studies with 61,193 patients across all adult age ranges 3. There are no age-related restrictions for adults, and the standard adult reference range (normal 4.4-5.5 kPa) applies 4.

Common Pitfalls and Confounders

Factors That Invalidate Results

Do not interpret FibroScan in these clinical scenarios:

  • Intercurrent illness (even non-hepatological) significantly elevates readings (5.2 vs 4.1 kPa in healthy children, p=0.0001) 2
  • Acute hepatitis or active inflammation 4
  • Recent alcohol consumption 4
  • Food intake within 2-3 hours 4
  • Congestive heart failure 4
  • Extrahepatic cholestasis 4
  • Obesity (may require XL probe) 4

Quality Control Requirements

  • Minimum 10 valid measurements required 4, 1
  • Interquartile range/median (IQR/M) must be ≤30% 4, 2
  • Invalid measurements correlate with younger age, higher stiffness values, and longer examination times 1

Diagnostic Performance Limitations

Steatosis Detection (CAP)

The controlled attenuation parameter shows poor correlation with actual liver fat content in children. A 2026 study found CAP had only 0.61 AUC for detecting moderate steatosis (S2+) in pediatric NAFLD patients 5, and a 2023 study found no significant correlation between CAP and MRI-PDFF (r=0.17, p=0.5) 6.

Fibrosis Detection

  • Best performance for advanced fibrosis (F3-4): AUC 0.941 in young children with chronic hepatitis B 7
  • Limited performance for significant fibrosis (F2+): AUC ranges 0.56-0.71 in pediatric cohorts 7, 5
  • Performance varies significantly by underlying liver disease etiology 3

Guideline-Based Recommendations

The 2025 AASLD systematic review, representing the most comprehensive and recent evidence, confirms that liver stiffness measurement from transient elastography shows acceptable to outstanding accuracy across various liver disease etiologies, with accuracy increasing from F2-4 to F3-4 and highest for F4 3. The guideline explicitly states this applies to both adults and children.

Bottom line: Use FibroScan in children ≥6 years and all adults under 35, but apply age-appropriate reference values, ensure quality control metrics are met, and avoid interpretation during intercurrent illness or other confounding conditions.

References

Related Questions

What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
How long does bupivacaine take to wear off?
I just took 200 mg oral labetalol as an inpatient in my hospital room (not in the emergency department). What should I do now while waiting to speak with a provider?
Can quetiapine (Seroquel) cause hot flashes, and what are the recommended management steps?
Is the FIB‑4 index reliable for patients under 35 years old?
What parameters does a pulse oximeter measure?
In a patient with ICU sepsis, what organisms does each of the following antibiotics cover: tobramycin, cefepime, and ceftaroline?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.